EXCLUSIVE COMMERCIALIZATION AND IP AGREEMENTExclusive Commercialization and Ip Agreement • September 27th, 2024 • Biostem Technologies • Florida
This EXCLUSIVE COMMERCIALIZATION AND INTELLECTUAL PROPERTY (“IP”) AGREEMENT (together with its Exhibit(s), the “Agreement”) is entered into and made effective as of June 29, 2023 (the “Effective Date”) by and between (i) BioStem Technologies, Inc., a Florida corporation (“BioStem”), and (ii) Hesed Life and Medical, LLC, a California limited liability company (“Hesed Life”).
